Lyanne Harrison
Stock Analyst at Bank of America Securities
(1.07)
# 3,962
Out of 5,136 analysts
56
Total ratings
55%
Success rate
-2.4%
Average return
Main Sectors:
Stocks Rated by Lyanne Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Reiterated: Buy | $320 | $238.19 | +34.35% | 44 | Nov 2, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Upgraded: Buy | $3.60 | $3.32 | n/a | 1 | Jun 23, 2025 | |
| RCEL AVITA Medical | Reiterated: Buy | n/a | $15.22 | n/a | 10 | Aug 9, 2024 | |
| ASX: SIG Sigma Healthcare Limited | Upgraded: Hold | $0.85 | $2.87 | n/a | 1 | Jun 7, 2023 |
ResMed
Nov 2, 2026
Reiterated: Buy
Price Target: $320
Current: $238.19
Upside: +34.35%
Australian Clinical Labs Limited
Jun 23, 2025
Upgraded: Buy
Price Target: $3.60
Current: $3.32
Upside: n/a
AVITA Medical
Aug 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $15.22
Upside: n/a
Sigma Healthcare Limited
Jun 7, 2023
Upgraded: Hold
Price Target: $0.85
Current: $2.87
Upside: n/a